## Cardiac Output in LVH with Preserved Ejection Fraction **Key Point:** In this patient with LVH and diastolic dysfunction, the question asks which intervention will **NOT** increase cardiac output (CO = HR × SV). Option D (atropine-induced tachycardia) is the EXCEPT answer because increasing HR from 60→100 bpm is the **least effective** intervention and may actually reduce or fail to increase CO in diastolic dysfunction. ### Pathophysiology of LVH with Preserved EF - Chronic hypertension → increased afterload → compensatory concentric LVH - Diastolic dysfunction (impaired relaxation and reduced compliance) develops - Systolic function preserved (EF normal) at rest - **Critical limitation:** Stiff, non-compliant ventricle is highly preload-dependent; diastolic filling is already impaired ### Analysis of Each Intervention | Intervention | Effect on CO | Mechanism | |--------------|--------------|-----------| | **Dobutamine** (↑ contractility) | **↑ CO** | β1-agonist increases force of contraction and SV; also has mild lusitropic effect improving diastolic relaxation | | **Nitroprusside** (↓ afterload/SVR) | **↑ CO** | Reduces wall tension and afterload → improves SV per Frank-Starling; net CO increases in most clinical scenarios | | **Leg elevation + fluids** (↑ preload) | **↑ CO** | Increases ventricular filling → Frank-Starling mechanism; LVH hearts are preload-sensitive | | **Atropine** (↑ HR 60→100) | **Minimal/No ↑ CO** | Tachycardia shortens diastolic filling time → ↓ SV; in diastolic dysfunction, this is particularly detrimental as the stiff ventricle needs adequate time to fill | **High-Yield (Guyton & Hall / Harrison's):** In **diastolic dysfunction** (as in LVH with preserved EF): - Increased HR reduces diastolic filling time disproportionately - The stiff, non-compliant LV cannot compensate by increasing filling pressure rapidly - Net result: HR × SV may not increase meaningfully, or CO may even decrease - **Contrast:** In normal hearts, modest HR increase (60→100) reliably increases CO because diastolic filling reserve is intact > **Clinical Pearl:** The SME note correctly highlights that in some patients with preserved diastolic reserve, a modest HR increase *might* slightly increase CO. However, among all four options, atropine-induced tachycardia is the **least likely** to increase CO and most likely to be detrimental — making it the best "EXCEPT" answer. The other three interventions (inotrope, afterload reduction, preload augmentation) reliably increase CO in this setting. **Why not Option B (nitroprusside)?** While nitroprusside reduces preload (venodilation) in addition to afterload, the dominant effect in a patient with elevated SVR (hypertension) is afterload reduction → increased SV → net increase in CO. Excessive preload reduction could theoretically reduce CO, but this is not the primary expected effect at therapeutic doses in a hypertensive patient. **Mnemonic — CO optimization in LVH (SAID):** - **S**ympathomimetics (inotropes) — ↑ CO ✓ - **A**fterload reduction — ↑ CO ✓ - **I**ncrease preload (fluids, leg elevation) — ↑ CO ✓ - **D**on't increase HR (avoid tachycardia) — ✗ EXCEPT answer
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.